Neurology

Study identifies characteristics that may constitute the MS prodrome

REPORTING FROM ACTRIMS FORUM 2018 San Diego (FRONTLINE MEDICAL NEWS) – Compared with controls, ...

Nearly half of MS patients treated by primary docs miss out on meds

REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Multiple sclerosis (MS) ...

MS may be a transmissible protein misfolding disorder, study suggests

REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Multiple sclerosis appears ...

No improvement in sight for Alzheimer’s drug development

Another one bites the dust. Yet another investigational agent joins intepirdine, verubecestat, solanezumab, bapineuzumab, ...

Fingolimod cuts pediatric MS relapse rate more than interferon beta-1a

FROM ACTRIMS FORUM 2018 Pediatric patients with relapsing remitting multiple sclerosis (MS) had fewer ...

Study finds rising use of newer DMTs in pediatric-onset MS

FROM ACTRIMS FORUM 2018 Newer disease-modifying therapies are often used in patients with pediatric-onset ...